CCL5 and metabolic dysfunction-associated steatohepatitis: It has also been shown to promote the production of profibrotic cytokines (including CCL2 and CCL5), which activate hepatic stellate cells (HSC) and promote inflammation and fibrosis in NAFLD/NASH [37,38].